Jul 16, 2018 - Mcrae Capital Management Inc Buys Wyndham Hotels & Resorts Inc, Procter & Gamble Co, Wyndham Destinations Inc, Sells Barings Global Short Duration High Yield Fund, Bristol-Myers Squibb Company, JM Smucker Co, Stocks: PG,PFE,TPR,T,AMGN,HD,WH,WYND,FDX,NVT,ICE,TXN,BMY,W, release date:Jul 16, 2018
Jul 16, 2018 - The Jim Carrey Parable, Stocks: AMZN,FB,GOOGL,TGT,KR,WBA,AMGN,MRK,PFE,JNJ,DISCA, Howard Marks, release date:Jul 16, 2018
Jul 16, 2018 - Pacira (PCRX) focuses on the label expansion of its flagship product, Exparel.
Jul 16, 2018 - Health Is Expensive – These Stocks Are Primed for Growth, release date:Jul 15, 2018
Jul 16, 2018 - Allergan is under pressure from activist shareholders and other investors to formulate a clear strategic plan and make more drastic changes to the company.Botox Aesthetics, Botox Migraine, and Restasi
Jul 16, 2018 - FDA approves Pfizer's (PFE) sNDA to expand the label of Xtandi to include the non-metastatic prostate cancer patient population.
Jul 16, 2018 - FDA lifts hold on Advaxis trial.Atossa commences Phase 2 trial.Amgen files a fresh NDA.
Jul 16, 2018 - Celgene amends protocol for phase 2 multiple myeloma study.FDA accepts BLA from Roche for subcutaneous version of Herceptin.Amgen and UCB resubmit BLA application for osteoporosis drug.
Jul 16, 2018 - Swiss-giant Novartis (NVS) is all set to report second-quarter 2018 earnings on Jul 18. While the pharma business should maintain growth, the generic division is expected to be laggard.
Jul 15, 2018 - Biogen and Amgen have been two of the best performing biotechs for a decade. But one stock clearly has an easier path toward value creation.